These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 28336290

  • 1. Serum microRNA Expression Profiling: Potential Diagnostic Implications of a Panel of Serum microRNAs for Clear Cell Renal Cell Cancer.
    Yadav S, Khandelwal M, Seth A, Saini AK, Dogra PN, Sharma A.
    Urology; 2017 Jun; 104():64-69. PubMed ID: 28336290
    [Abstract] [Full Text] [Related]

  • 2. MicroRNAs in Serum Exosomes as Potential Biomarkers in Clear-cell Renal Cell Carcinoma.
    Zhang W, Ni M, Su Y, Wang H, Zhu S, Zhao A, Li G.
    Eur Urol Focus; 2018 Apr; 4(3):412-419. PubMed ID: 28753793
    [Abstract] [Full Text] [Related]

  • 3. miR-144-3p as a novel plasma diagnostic biomarker for clear cell renal cell carcinoma.
    Lou N, Ruan AM, Qiu B, Bao L, Xu YC, Zhao Y, Sun RL, Zhang ST, Xu GH, Ruan HL, Yuan CF, Han WW, Shi HC, Yang HM, Zhang XP.
    Urol Oncol; 2017 Jan; 35(1):36.e7-36.e14. PubMed ID: 27633984
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. miRNA-27b-3p, let-7f-5p and miRNA-142-5p can be Used in a Novel Serum Diagnostic Panel for Clear Cell Renal Cell Carcinoma.
    He T, Lu C, Gong W, Ge Z, Li R, Li X, Sun C, Li W, Long Q, Liu Q, Lai Y.
    Front Biosci (Landmark Ed); 2024 May 13; 29(5):186. PubMed ID: 38812297
    [Abstract] [Full Text] [Related]

  • 7. Identification of dysregulated serum miR-508-3p and miR-885-5p as potential diagnostic biomarkers of clear cell renal carcinoma.
    Liu S, Deng X, Zhang J.
    Mol Med Rep; 2019 Dec 13; 20(6):5075-5083. PubMed ID: 31661117
    [Abstract] [Full Text] [Related]

  • 8. Profiling microRNA from nephrectomy and biopsy specimens: predictors of progression and survival in clear cell renal cell carcinoma.
    Kowalik CG, Palmer DA, Sullivan TB, Teebagy PA, Dugan JM, Libertino JA, Burks EJ, Canes D, Rieger-Christ KM.
    BJU Int; 2017 Sep 13; 120(3):428-440. PubMed ID: 28432832
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Profiling of Serum miRNAs Constructs a Diagnostic 3-miRNA Panel for Clear-Cell Renal Cell Carcinoma.
    Li X, Wen Z, Li R, Lu C, Chen W, Chen X, Huang G, Ni L, Lai Y, Tao L.
    Clin Genitourin Cancer; 2024 Feb 13; 22(1):23-32. PubMed ID: 37574436
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Analysis of serum microRNAs (miR-26a-2*, miR-191, miR-337-3p and miR-378) as potential biomarkers in renal cell carcinoma.
    Hauser S, Wulfken LM, Holdenrieder S, Moritz R, Ohlmann CH, Jung V, Becker F, Herrmann E, Walgenbach-Brünagel G, von Ruecker A, Müller SC, Ellinger J.
    Cancer Epidemiol; 2012 Aug 13; 36(4):391-4. PubMed ID: 22542158
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Clear cell papillary renal cell carcinoma: micro-RNA expression profiling and comparison with clear cell renal cell carcinoma and papillary renal cell carcinoma.
    Munari E, Marchionni L, Chitre A, Hayashi M, Martignoni G, Brunelli M, Gobbo S, Argani P, Allaf M, Hoque MO, Netto GJ.
    Hum Pathol; 2014 Jun 13; 45(6):1130-8. PubMed ID: 24703100
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.